High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa

American Journal of Hematology

Volumn 86, Issue 7, 2011, Pages 554-558

  Buadi, Francis ^a   Hsing, Ann W ^b   Katzmann, Jerry A ^a   Pfeiffer, Ruth M ^b   Waxman, Adam ^b,c   Yeboah, Edward D ^d   Biritwum, Richard B ^d   Tettey, Yao ^d   Adjei, Andrew ^d   Chu, Lisa W ^d   Demarzo, Angelo ^e   Netto, George J ^e   Dispenzieri, Angela ^a   Kyle, Robert A ^a   Rajkumar, S Vincent ^a   Landgren, Ola ^b  

^a Mayo Clinic College of Medicine   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF GHANA   (Ghana)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; EDUCATION; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GHANA; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOSTIMULATION; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SMOKING; SYPHILIS;

ADULT; AGED; GHANA; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 79959345935     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22040     Document Type: Article

References (36)

1. Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl J Med 2000; 343: 108-117.
2. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000; 343: 37-49.
3. Van Regenmortel MH. Antigenicity and immunogenicity of synthetic peptides. Biologicals 2001; 29: 209-213.
4. Buckley RH. Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 2004; 5(Suppl A): S225-S233.
5. Gorson KC, Ropper AH, Palmetshofer AK, et al. Prevalence of polyclonal gammopathy in polyneuropathy. Neurology 1997; 49: 1747.
6. Dispenzieri A, Gertz MA, Therneau TM, et al. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc 2001; 76: 476-487.
7. Axelsson U, Hallen J. The frequency of pronounced polyclonal hypergammaglobulinaemia in a random population. Acta Med Scand Suppl 1966; 445: 97-101.
8. Curtain CC, Kidson C, Gorman JG, et al. Tropical Hypergammaglobulinaemia and Tissue Antibodies. Trans R Soc Trop Med Hyg 1965; 59: 415-419.
9. Siegel M, Lee SL, Ginsberg V, et al. Racial differences in serum gamma globulin levels: Comparative data for Negroes, Puerto Ricans, and other Caucasians. J Lab Clin Med 1965; 66: 715-720.
10. Mili F, Flanders WD, Boring JR, et al. The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men. Clin Immunol Immunopathol 1991; 59: 187-200.
11. Shulman G, Cilich GC. Serum immunoglobulins in Black South African children. S Afr Med J 1976; 50: 1465-1467.
12. Albandar JM, DeNardin AM, Adesanya MR, et al. Associations of serum concentrations of IgG, IgA, IgM and interleukin-1beta with early-onset periodontitis classification and race. J Clin Periodontol 2002; 29: 421-426.
13. Penny R. Paraprotein patterns in Australia. Australas Ann Med 1969; 18: 251-257.
14. Landgren O, Gridley G, Turesson I, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006; 107: 904-906.
15. Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: Support for genetic factors in pathogenesis. Leukemia 2009; 23: 1691-1697.
16. Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: A population-based study. Blood 2010; 116: 5501-5506.
17. Brown LM, Gridley G, Check D, et al. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388-3394.
18. Gunsolley JC, Pandey JP, Quinn SM, et al. The effect of race, smoking and immunoglobulin allotypes on IgG subclass concentrations. J Periodontal Res 1997; 32: 381-387.
19. Lichtman MA, Vaughan JH, Hames CG. The distribution of serum immunoglobulins, anti-gamma-G globulins ("rheumatoid factors") and antinuclear antibodies in White and Negro subjects in Evans County, Georgia. Arthritis Rheum 1967; 10: 204-215.
20. Tollerud DJ, Brown LM, Blattner WA, et al. Racial differences in serum immunoglobulin levels: Relationship to cigarette smoking, T-cell subsets, and soluble interleukin-2 receptors. J Clin Lab Anal 1995; 9: 37-41.
21. Landgren O, Katzmann JA, Hsing AW, et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007; 82: 1468-1473.
22. Terhorst D, Kalali BN, Ollert M, et al. The role of toll-like receptors in host defenses and their relevance to dermatologic diseases. Am J Clin Dermatol 2010; 11: 1-10.
23. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010-2017.
24. Memeh C. Changes in serum protein profile of healthy adult Nigerians after three decades. Clin Physiol Biochem 1990; 8: 314-317.
25. Baris D, Brown LM, Silverman DT, et al. Socioeconomic status and multiple myeloma among US blacks and whites. Am J Public Health 2000; 90: 1277-1281.
26. Boffetta P, Stellman SD, Garfinkel L. A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer 1989; 43: 554-559.
27. Velez R, Beral V, Cuzick J. Increasing trends of multiple myeloma mortality in England and Wales; 1950-79: Are the changes real? J Natl Cancer Inst 1982; 69: 387-392.
28. Blattner WA, Mason TJ, Bair A. Changes in mortality rates from multiple myeloma. N Engl J Med 1980; 302: 814-815.
29. Vagero D, Norell SE. Mortality and social class in Sweden-exploring a new epidemiological tool. Scand J Soc Med 1989; 17: 49-58.
30. Blair CK, Cerhan JR, Folsom AR, et al. Anthropometric characteristics and risk of multiple myeloma. Epidemiology 2005; 16: 691-694.
31. Brown LM, Gridley G, Pottern LM, et al. Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control 2001; 12: 117-125.
32. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
33. Signorello LB, Hargreaves MK, Steinwandel MD, et al. Southern community cohort study: Establishing a cohort to investigate health disparities. J Natl Med Assoc 2005; 97: 972-979.
34. Landgren O, Rajkumar SV, Pfeiffer RM, et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood 2010; 116: 1056-1059.
35. Landgren O, Kristinsson SY, Goldin LR, et al. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood 2009; 114: 791-795.
36. Munshi NC. Monoclonal gammopathy of undetermined significance: Genetic vs environmental etiologies. Mayo Clin Proc. 2007; 82: 1457-1459.